The Scan

In letters, CRISPR companies respond to a Nature Methods report of off-target editing effects, Technology Review reports.

'Fun, But'

Business Insider reports that the science for tailoring diet advice on genetic and microbial analysis isn't there yet.

This Week in PLOS

In PLOS this week: root-knot nematode sequencing study, somatic mutations linked to uveal melanoma, and more.

Proove Biosciences responds to its visit by federal investigators and concerns surrounding its tests and business approaches.

Molecular and Cellular Biology won't consider misconduct allegations for papers that are more than six years old, Retraction Watch reports.

This Week in Science

In Science this week: tumors with mismatch repair defects are responsive to immunotherapy, and more.

Federal investigators have searched the offices of Proove Biosciences, Stat News reports.

Michelle Lee, the director of the United States Patent and Trademark Office, has resigned, IP Watchdog reports.

Wolf of a Debate

A technical comment in Science Advances argues that the data don't support a finding reported last year that eastern and red wolves are recent hybrids.

This Week in Nature

In Nature this week: high-quality de novo assembly of the apple genome, and more.

Collins to Stay

President Donald Trump has announced that Francis Collins will remain director of the US National Institutes of Health.

An opinion piece at Wired says that pre-implantation genetic diagnosis and in vitro fertilization could prevent many rare genetic diseases.

Someday, Maybe

US News & World Reports discusses how gene-editing approaches could be used to treat breast cancer.

In Nucleic Acids Research this week: efforts to recode the Salmonella typhimurium LT2 genome, Human Genome Variation Archive database, and more.

Bit Suspect

A new analysis has uncovered clinical trial papers that have reported suspicious data, the Guardian reports.

Researchers find a site on Mars that — if there ever had been life on the planet — would be a likely candidate for where to find it, the Los Angeles Times reports.

Technology Review writes that targeted cancer therapies require genetic testing, which many patients' insurers don't cover.

This Week in PNAS

In PNAS this week: statistical method for gene regulation evaluation, sea urchin gene regulatory networks, and more.

A new analysis finds that collagen thought to have belonged to Tyrannosaurus rex was likely contamination, the International Business Times reports.

What It's Like

A nursing professor got her genome sequenced to see whether her students would be ready for patients with such results, CBS SF reports.

Happier Reviewers?

The company Publons aims to make being a peer reviewer a more attractive task, the Economist reports.

This Week in PLOS

In PLOS this week: biobank for sleeping sickness research, skin microbiome of cats with allergies, and more.

23andMe And Pain

23andMe is asking its customers to do some at-home research in order to find genetic variants that affect pain levels, says Technology Review.

According to Nature News, researchers are moving toward measuring biodiversity by the quality of functional variants rather than just the quantity of species.

Look into the Issue

A study of bias in US National Institutes of Health grant-awarding process is to start later this year, ScienceInsider reports.


A research duo finds that science and technology graduate students who turn away from academic careers do so because of changes in their own interests.

Students whose classmates are interested in science are more likely to think about a career in science, technology, engineering, and mathematics, a new study says.

CNBC reports that the genetic counseling field is expected to grow as personalized medicine becomes more common.

Gladys Kong writes at Fortune that her STEM background has helped her as a CEO.